Business Description
DataMEDS AI Inc
NAICS : 423450
SIC : 5122
ISIN : US9495031067
Compare
Compare
Traded in other countries / regions
MEDS.USA IPO Date
2025-02-21Description
DataMEDS AI Inc is a healthcare technology and pharmaceutical logistics company. The group simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. Its solutions provide a single, integrated platform for pharmacies, wholesale distribution, and a fulfillment network focused on Independent Pharmacies and Specialty Lite medications.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Equity-to-Asset | -0.5 | |||||
Debt-to-Equity | -1.92 | |||||
Debt-to-EBITDA | -0.42 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -13.89 | |||||
Beneish M-Score | -11.92 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -22 | |||||
3-Year EBITDA Growth Rate | -452.7 | |||||
3-Year EPS without NRI Growth Rate | -132.4 | |||||
3-Year Book Growth Rate | -971.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 51.82 | |||||
9-Day RSI | 51.14 | |||||
14-Day RSI | 49.22 | |||||
3-1 Month Momentum % | -45.02 | |||||
6-1 Month Momentum % | -83.53 | |||||
12-1 Month Momentum % | -92.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.09 | |||||
Quick Ratio | 0.03 | |||||
Days Inventory | 103.01 | |||||
Days Sales Outstanding | 42.74 | |||||
Days Payable | 180.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24.9 | |||||
Shareholder Yield % | -109.57 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -49.51 | |||||
Operating Margin % | -398.02 | |||||
Net Margin % | -545.68 | |||||
EBITDA Margin % | -486.38 | |||||
FCF Margin % | -97.85 | |||||
OCF Margin % | -92.06 | |||||
ROA % | -169.7 | |||||
ROIC % | -102.14 | |||||
ROC (Joel Greenblatt) % | -5166.42 | |||||
ROCE % | -839.46 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.33 | |||||
EV-to-EBIT | -0.54 | |||||
EV-to-EBITDA | -0.56 | |||||
EV-to-Revenue | 2.71 | |||||
EV-to-FCF | -2.77 | |||||
Earnings Yield (Greenblatt) % | -185.19 | |||||
FCF Yield % | -148.9 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MEDS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DataMEDS AI Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 14.035 | ||
| EPS (TTM) ($) | -44.5 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 91.15 | ||
| 14-Day RSI | 49.22 | ||
| 14-Day ATR ($) | 0.437398 | ||
| 20-Day SMA ($) | 3.058085 | ||
| 12-1 Month Momentum % | -92.9 | ||
| 52-Week Range ($) | 2.4848 - 97.5 | ||
| Shares Outstanding (Mil) | 2.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DataMEDS AI Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DataMEDS AI Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-20 | In 108 days | ||
| Second quarter earnings results for 2026 | 2026-08-19 | In 15 days | ||
| General meeting for 2025 | 2026-06-19 13:00 | 3.39 (-7.12%) | ||
| 0.02:1 Stock Split | 2026-05-26 | 4.14 (-15.70%) | ||
| First quarter earnings results for 2026 | 2026-05-19 | 8.70 (+95.51%) | ||
| Annual report for 2025 | 2026-03-20 | 6.00 (-8.47%) | ||
| Third quarter earnings results for 2025 | 2025-11-20 | 28.95 (-1.30%) | ||
| Skyline Signature Series Webinar | 2025-09-30 12:00 | 47.00 (-6.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-19 | 37.50 (+2.32%) | ||
| First quarter earnings results for 2025 | 2025-05-12 | 135.50 (-3.90%) |
Show
Entries
DataMEDS AI Inc Frequently Asked Questions
What is DataMEDS AI Inc(MEDS)'s stock price today?
The current price of MEDS is $3.18. The 52 week high of MEDS is $97.50 and 52 week low is $2.48.
When is next earnings date of DataMEDS AI Inc(MEDS)?
The next earnings date of DataMEDS AI Inc(MEDS) is 2026-08-19 Est..
Does DataMEDS AI Inc(MEDS) pay dividends? If so, how much?
DataMEDS AI Inc(MEDS) does not pay dividend.
Guru Commentaries on NAS:MEDS
No articles.
Press Release
Articles on DataMEDS AI Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers